Lexeo Therapeutics, Inc. files Q3 2026 report, showing growth in biological products sector. Key financial data and strategic initiatives highlighted.
| Name | Lexeo Therapeutics, Inc. |
|---|---|
| CIK | 0001907108 |
| Tickers | LXEO |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 854012572 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | (212) 547-9879 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Lexeo Therapeutics, Inc. files Q3 2026 report, showing growth in biological products sector. Key financial data and strategic initiatives highlighted.
Lexeo Therapeutics announces its Q3 2026 financial results, showcasing significant developments in the biological products sector.
State Street Corporation has reported a 4.4% stake in Lexeo Therapeutics, potentially impacting investor confidence in the biological products sector.
Lexeo Therapeutics, Inc. has received effectiveness for its S-3 registration statement, enhancing its capital-raising capabilities in the biological products sector.
Lexeo Therapeutics has filed a registration statement for a $300 million securities offering, aiming to bolster its capital for ongoing projects.
378 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 4 | xslF345X06/form4-11182026_051106.xml | 0002083206-26-000011 | 5480 | ||||||
| 2026-11-18 | 4 | xslF345X06/form4-11182026_051104.xml | 0002024096-26-000017 | 5532 | ||||||
| 2026-11-18 | 4 | xslF345X06/form4-11182026_051101.xml | 0001995218-26-000019 | 5544 | ||||||
| 2026-11-17 | 4 | xslF345X06/form4-11172026_101144.xml | 0001678984-26-000005 | 5676 | ||||||
| 2026-11-17 | 3 | xslF345X06/form3-11172026_101105.xml | 0001678984-26-000004 | 7850 | ||||||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-008104 | 001-41855 | 261565861 | 33 | 5205 | |||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-008101 | 001-41855 | 261565831 | 33 | 5073 | |||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-008097 | 001-41855 | 261565738 | 33 | 5117 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000947871-26-001037 | 005-94231 | 261563373 | 34 | 15099 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-004577 | 005-94231 | 261561230 | 34 | 11296 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128311 | 005-94231 | 261560942 | 34 | 12260 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001274173-26-000240 | 005-94231 | 261558088 | 34 | 13090 | |||
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-462020 | 001-41855 | 261555357 | 34 | 13683602 | 1 | 1 | |
| 2026-11-16 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-26-462015 | 001-41855 | 261555352 | 34 | 28949212 | 1 | 1 |
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005050 | 005-94231 | 261555108 | 34 | 15713 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000696 | 005-94231 | 261552769 | 34 | 10850 | |||
| 2026-11-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000685 | 005-94231 | 261538106 | 34 | 7971 | |||
| 2026-11-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003444 | 333-299689 | 261524453 | 33 | 1746 | ||
| 2026-10-29 | S-3 | S-3 | 0001193125-26-437001 | 333-299689 | 261497508 | 33 | 890279 | 1 | 1 | |
| 2026-10-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000019617-26-000349 | 005-94231 | 261456256 | 34 | 6659 | |||
| 2026-09-29 | 8-K | 8-K | 2.01,3.02,9.01 | 0001193125-26-407555 | 001-41855 | 261424072 | 34 | 184907 | 1 | 1 |
| 2026-09-28 | 4 | xslF345X06/form4-09282026_050908.xml | 0002083206-26-000009 | 5628 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_050906.xml | 0002109299-26-000009 | 7557 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_050904.xml | 0002024096-26-000015 | 7603 | ||||||
| 2026-09-28 | 4 | xslF345X06/form4-09282026_050901.xml | 0001995218-26-000017 | 7618 | ||||||
| 2026-09-22 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-26-397221 | 001-41855 | 261395232 | 34 | 8630822 | 1 | 1 |
| 2026-08-19 | 4 | xslF345X06/form4-08192026_050809.xml | 0002083206-26-000007 | 5482 | ||||||
| 2026-08-19 | 4 | xslF345X06/form4-08192026_050805.xml | 0001995218-26-000015 | 5546 | ||||||
| 2026-08-19 | 4 | xslF345X06/form4-08192026_050801.xml | 0002024096-26-000013 | 5534 | ||||||
| 2026-08-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-006154 | 001-41855 | 261290182 | 33 | 5843 | |||
| 2026-08-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-006153 | 001-41855 | 261290154 | 33 | 5750 | |||
| 2026-08-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-006152 | 001-41855 | 261290102 | 33 | 5073 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000947871-26-000801 | 005-94231 | 261283956 | 34 | 15511 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097207 | 005-94231 | 261282222 | 34 | 12445 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003428 | 005-94231 | 261275817 | 34 | 15712 | |||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000515 | 005-94231 | 261273482 | 34 | 9646 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-345724 | 001-41855 | 261265290 | 34 | 11692731 | 1 | 1 | |
| 2026-08-12 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-345722 | 001-41855 | 261265282 | 34 | 18840589 | 1 | 1 |
| 2026-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000489 | 005-94231 | 261252003 | 34 | 8097 | |||
| 2026-07-01 | 4 | xslF345X06/form4-07012026_100733.xml | 0002083206-26-000005 | 7036 | ||||||
| 2026-07-01 | 4 | xslF345X06/form4-07012026_100702.xml | 0002024096-26-000011 | 7089 | ||||||
| 2026-07-01 | 4 | xslF345X06/form4-07012026_100718.xml | 0002109299-26-000007 | 7044 | ||||||
| 2026-07-01 | 4 | xslF345X06/form4-07012026_100715.xml | 0001995218-26-000013 | 7105 | ||||||
| 2026-07-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005036 | 001-41855 | 261146174 | 33 | 5122 | |||
| 2026-07-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005033 | 001-41855 | 261145984 | 33 | 4441 | |||
| 2026-07-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005032 | 001-41855 | 261145982 | 33 | 4459 | |||
| 2026-07-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005031 | 001-41855 | 261145960 | 33 | 5211 | |||
| 2026-06-29 | 8-K | 8-K | 5.07 | 0001193125-26-288703 | 001-41855 | 261136792 | 34 | 162956 | 1 | 1 |
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080651.xml | 0001458116-26-000002 | 5653 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080602.xml | 0001722234-26-000002 | 5664 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080620.xml | 0001931514-26-000002 | 5668 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080624.xml | 0001250086-26-000002 | 5635 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080640.xml | 0001849458-26-000001 | 5640 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080640.xml | 0001816206-26-000005 | 5657 | ||||||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_080630.xml | 0001193675-26-000002 | 5693 | ||||||
| 2026-06-15 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-270275 | 001-41855 | 261089016 | 34 | 24203296 | 1 | 1 |
| 2026-05-20 | 4 | xslF345X06/form4-05202026_040507.xml | 0002024096-26-000009 | 5534 | ||||||
| 2026-05-20 | 4 | xslF345X06/form4-05202026_040505.xml | 0001995218-26-000011 | 5546 | ||||||
| 2026-05-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003723 | 001-41855 | 26992770 | 33 | 5212 | |||
| 2026-05-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003717 | 001-41855 | 26992691 | 33 | 5129 | |||
| 2026-05-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003716 | 001-41855 | 26992685 | 33 | 5101 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062613 | 005-94231 | 26988222 | 34 | 12440 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-225157 | 005-94231 | 26981982 | 34 | 142091 | |||
| 2026-05-11 | 10-Q | 10-Q | 0001193125-26-215678 | 001-41855 | 26960834 | 34 | 10202743 | 1 | 1 | |
| 2026-05-11 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-215674 | 001-41855 | 26960826 | 34 | 17108284 | 1 | 1 |
| 2026-04-30 | 4 | xslF345X06/form4-04302026_080451.xml | 0001777421-26-000003 | 5680 | ||||||
| 2026-04-30 | 3 | xslF345X06/form3-04302026_080417.xml | 0001777421-26-000002 | 7933 | ||||||
| 2026-04-30 | ARS | ARS | 0001193125-26-193939 | 001-41855 | 26920011 | 34 | 1722298 | |||
| 2026-04-30 | DEFA14A | DEFA14A | 0001193125-26-193935 | 001-41855 | 26920002 | 34 | 999966 | |||
| 2026-04-30 | DEF 14A | DEF 14A | 0001193125-26-193930 | 001-41855 | 26919990 | 34 | 2222599 | |||
| 2026-04-30 | 8-K | 8-K | 5.02 | 0001193125-26-193927 | 001-41855 | 26919974 | 34 | 159277 | 1 | 1 |
| 2026-04-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-002223 | 005-94231 | 26858436 | 34 | 16788 | |||
| 2026-04-07 | 4 | xslF345X06/form4-04072026_040401.xml | 0001995218-26-000009 | 5726 | ||||||
| 2026-04-06 | 144 | xsl144X01/primary_doc.xml | 0001968582-26-000351 | 001-41855 | 26841312 | 33 | 4488 | |||
| 2026-03-30 | S-8 | S-8 | 0001193125-26-132423 | 333-294751 | 26815567 | 33 | 470582 | 1 | 1 | |
| 2026-03-30 | 10-K | 10-K | 0001193125-26-132085 | 001-41855 | 26813842 | 34 | 18365497 | 1 | 1 | |
| 2026-03-30 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-131792 | 001-41855 | 26813145 | 34 | 16988264 | 1 | 1 |
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001619 | 005-94231 | 26801837 | 34 | 7163 | |||
| 2026-03-17 | 4 | xslF345X05/form4-03182026_010332.xml | 0001995218-26-000006 | 5079 | ||||||
| 2026-03-17 | 4 | xslF345X05/form4-03182026_010330.xml | 0002024096-26-000007 | 5068 | ||||||
| 2026-02-20 | 4 | xslF345X05/form4-02202026_050205.xml | 0002024096-26-000005 | 5402 | ||||||
| 2026-02-20 | 4 | xslF345X05/form4-02202026_050203.xml | 0001995218-26-000004 | 5413 | ||||||
| 2026-02-20 | 4/A | xslF345X05/form4a-02202026_050201.xml | 0002024096-26-000004 | 5765 | ||||||
| 2026-02-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-001161 | 001-41855 | 26648769 | 33 | 5211 | |||
| 2026-02-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-001152 | 001-41855 | 26647989 | 33 | 5123 | |||
| 2026-02-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-001143 | 001-41855 | 26647834 | 33 | 5194 | |||
| 2026-02-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-001141 | 001-41855 | 26647746 | 33 | 5124 | |||
| 2026-02-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-001140 | 001-41855 | 26647744 | 33 | 5102 | |||
| 2026-02-17 | 4 | xslF345X05/form4-02172026_040201.xml | 0002109299-26-000004 | 7600 | ||||||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-016498 | 005-94231 | 26642566 | 34 | 18511 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-016355 | 005-94231 | 26640724 | 34 | 12350 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-26-052896 | 005-94231 | 26636155 | 34 | 127138 | |||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001231919-26-000153 | 005-94231 | 26634868 | 34 | 44905 | |||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_050205.xml | 0001995218-26-000002 | 7654 | ||||||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_050203.xml | 0002024096-26-000002 | 7642 | ||||||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_050201.xml | 0002083206-26-000002 | 7601 | ||||||
| 2026-02-05 | 3 | xslF345X02/form3-02052026_090214.xml | 0002109299-26-000002 | 7760 | ||||||
| 2026-02-05 | 8-K | 8-K | 5.02 | 0001193125-26-039425 | 001-41855 | 26603117 | 34 | 153301 | 1 | 1 |
| 2026-01-30 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-26-000183 | 005-94231 | 26582347 | 34 | 6961 | |||
| 2026-01-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001315863-26-000099 | 005-94231 | 26579987 | 34 | 15747 | |||
| 2026-01-27 | 8-K | 8-K | 5.02 | 0001193125-26-023339 | 001-41855 | 26562048 | 34 | 155969 | 1 | 1 |
| 2026-01-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000688 | 005-94231 | 26545921 | 34 | 10743 | |||
| 2026-01-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-010091 | 001-41855 | 26525540 | 34 | 22663349 | 1 | 1 |
| 2025-12-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000338 | 005-94231 | 251555164 | 34 | 9978 | |||
| 2025-11-26 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003406 | 333-291269 | 251532236 | 33 | 1746 | ||
| 2025-11-26 | 424B3 | 424B3 | 0001193125-25-300634 | 333-291269 | 251530742 | 33 | 185628 | |||
| 2025-11-25 | CORRESP | filename1.htm | 0001193125-25-297231 | 7702 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11202025_101125.xml | 0001995218-25-000007 | 5407 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11202025_101109.xml | 0001994972-25-000005 | 5361 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11202025_101104.xml | 0002009350-25-000005 | 5426 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11202025_101103.xml | 0001995009-25-000005 | 5369 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11202025_101149.xml | 0002024096-25-000005 | 5375 | ||||||
| 2025-11-20 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-114635 | 005-94231 | 251503447 | 34 | 15880 | |||
| 2025-11-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007114 | 001-41855 | 251494316 | 33 | 5763 | |||
| 2025-11-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007113 | 001-41855 | 251494278 | 33 | 5823 | |||
| 2025-11-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007112 | 001-41855 | 251494269 | 33 | 5745 | |||
| 2025-11-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007110 | 001-41855 | 251494229 | 33 | 5729 | |||
| 2025-11-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007105 | 001-41855 | 251494100 | 33 | 5841 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-283019 | 005-94231 | 251486584 | 34 | 16158 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004978 | 005-94231 | 251485466 | 34 | 11183 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000315 | 005-94231 | 251483729 | 34 | 10683 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-281249 | 005-94231 | 251480837 | 34 | 126592 | |||
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-108535 | 005-94231 | 251463265 | 34 | 18215 | |||
| 2025-11-05 | S-3 | S-3 | 0001193125-25-265934 | 333-291269 | 251452041 | 33 | 433044 | 1 | 1 | |
| 2025-11-05 | S-8 | S-8 | 0001193125-25-265784 | 333-291268 | 251451841 | 33 | 852189 | 1 | 1 | |
| 2025-11-05 | 10-Q | 10-Q | 0001193125-25-265757 | 001-41855 | 251451822 | 34 | 13109101 | 1 | 1 | |
| 2025-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-265755 | 001-41855 | 251451802 | 34 | 687837 | 1 | 1 |
| 2025-10-27 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-25-000027 | 005-94231 | 251419954 | 34 | 18996 | |||
| 2025-10-17 | 4 | xslF345X05/form4-10172025_111028.xml | 0002009350-25-000003 | 8973 | ||||||
| 2025-10-17 | 4 | xslF345X05/form4-10172025_111049.xml | 0001995009-25-000003 | 8915 | ||||||
| 2025-10-17 | 4 | xslF345X05/form4-10172025_111011.xml | 0002024096-25-000003 | 8921 | ||||||
| 2025-10-17 | 4 | xslF345X05/form4-10172025_111047.xml | 0001994972-25-000003 | 8907 | ||||||
| 2025-10-17 | 4 | xslF345X05/form4-10172025_111000.xml | 0001995218-25-000005 | 8939 | ||||||
| 2025-10-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-002600 | 005-94231 | 251401854 | 34 | 10796 | |||
| 2025-10-17 | 8-K | 8-K | 1.01,2.02,3.02,8.01,9.01 | 0001193125-25-242652 | 001-41855 | 251401634 | 34 | 1041433 | 1 | 1 |
| 2025-10-17 | 424B5 | 424B5 | 0001193125-25-242649 | 333-283781 | 251401622 | 33 | 594533 | |||
| 2025-10-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006492 | 001-41855 | 251401186 | 33 | 5102 | |||
| 2025-10-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006487 | 001-41855 | 251401020 | 33 | 5126 | |||
| 2025-10-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006485 | 001-41855 | 251400995 | 33 | 5137 | |||
| 2025-10-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006484 | 001-41855 | 251400957 | 33 | 5207 | |||
| 2025-10-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006483 | 001-41855 | 251400930 | 33 | 5187 | |||
| 2025-10-17 | FWP | FWP | 0001193125-25-241803 | 333-283781 | 251398836 | 34 | 22016 | |||
| 2025-10-16 | 424B5 | 424B5 | 0001193125-25-241560 | 333-283781 | 251398413 | 33 | 634911 | |||
| 2025-10-16 | FWP | FWP | 0001193125-25-241436 | 333-283781 | 251397827 | 34 | 21955 | |||
| 2025-10-07 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-232514 | 001-41855 | 251378177 | 34 | 11537001 | 1 | 1 |
| 2025-09-16 | 4 | xslF345X05/form4-09162025_050903.xml | 0001995218-25-000003 | 5080 | ||||||
| 2025-09-10 | 4/A | xslF345X05/form4a-09102025_080929.xml | 0001415889-25-024104 | 5333 | ||||||
| 2025-09-03 | 4 | xslF345X05/form4-09032025_020901.xml | 0001415889-25-023491 | 7599 | ||||||
| 2025-08-27 | 3 | xslF345X02/form3-08272025_100828.xml | 0001415889-25-023188 | 7968 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090801.xml | 0001415889-25-022479 | 4901 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090842.xml | 0001415889-25-022477 | 4894 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090811.xml | 0001415889-25-022475 | 4886 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_090813.xml | 0001415889-25-022473 | 4914 | ||||||
| 2025-08-20 | 4 | xslF345X05/form4-08202025_080818.xml | 0001415889-25-022468 | 4951 | ||||||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-005296 | 001-41855 | 251227702 | 33 | 4493 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-005294 | 001-41855 | 251227682 | 33 | 4478 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-005292 | 001-41855 | 251227675 | 33 | 4576 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-005291 | 001-41855 | 251227660 | 33 | 4558 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-005289 | 001-41855 | 251227656 | 33 | 4484 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-078747 | 005-94231 | 251220609 | 34 | 18417 | |||
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003607 | 005-94231 | 251218184 | 34 | 15387 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-021791 | 005-94231 | 251217123 | 34 | 48695 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000249 | 005-94231 | 251216018 | 34 | 10683 | |||
| 2025-08-14 | 10-Q | 10-Q | 0000950170-25-108427 | 001-41855 | 251214361 | 34 | 11412894 | 1 | 1 | |
| 2025-08-14 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-25-108426 | 001-41855 | 251214359 | 34 | 710038 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-180317 | 005-94231 | 251214173 | 34 | 136402 | |||
| 2025-08-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-075208 | 005-94231 | 251194354 | 34 | 18140 | |||
| 2025-07-01 | 424B3 | 424B3 | 0001193125-25-153484 | 333-288025 | 251094205 | 33 | 216683 | |||
| 2025-06-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002095 | 333-288025 | 251094056 | 33 | 1746 | ||
| 2025-06-30 | 4 | xslF345X05/form4-06302025_050616.xml | 0001415889-25-018524 | 5502 | ||||||
| 2025-06-30 | 4 | xslF345X05/form4-06302025_050614.xml | 0001415889-25-018523 | 5519 | ||||||
| 2025-06-30 | 4 | xslF345X05/form4-06302025_050611.xml | 0001415889-25-018522 | 5497 | ||||||
| 2025-06-30 | 4 | xslF345X05/form4-06302025_050609.xml | 0001415889-25-018521 | 5530 | ||||||
| 2025-06-30 | 4 | xslF345X05/form4-06302025_050606.xml | 0001415889-25-018520 | 5555 | ||||||
| 2025-06-30 | 4 | xslF345X05/form4-06302025_050604.xml | 0001415889-25-018519 | 5508 | ||||||
| 2025-06-30 | 4 | xslF345X05/form4-06302025_050601.xml | 0001415889-25-018518 | 5526 | ||||||
| 2025-06-30 | 8-K | 8-K | 5.07 | 0000950170-25-091671 | 001-41855 | 251092777 | 34 | 161796 | 1 | 1 |
| 2025-06-27 | CORRESP | filename1.htm | 0001193125-25-151402 | 7085 | ||||||
| 2025-06-26 | CORRESP | filename1.htm | 0001193125-25-149103 | 31593 | ||||||
| 2025-06-26 | S-3/A | S-3/A | 0001193125-25-149094 | 333-288025 | 251081101 | 33 | 320915 | |||
| 2025-06-18 | UPLOAD | filename1.pdf | 0000000000-25-006429 | 333-288025 | 43531 | |||||
| 2025-06-13 | S-3 | S-3 | 0001193125-25-140744 | 333-288025 | 251046600 | 33 | 340485 | |||
| 2025-06-05 | DEFA14A | DEFA14A | 0000950170-25-082440 | 001-41855 | 251027834 | 34 | 17023 | |||
| 2025-06-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-015606 | 005-94231 | 251023840 | 34 | 82759 | |||
| 2025-06-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001999371-25-007159 | 005-94231 | 251023088 | 34 | 9756 | |||
| 2025-05-27 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0000950170-25-077377 | 001-41855 | 25984202 | 34 | 1803384 | 1 | 1 |
| 2025-05-20 | 4 | xslF345X05/form4-05202025_050509.xml | 0001415889-25-013819 | 4913 | ||||||
| 2025-05-20 | 4 | xslF345X05/form4-05202025_050506.xml | 0001415889-25-013818 | 4885 | ||||||
| 2025-05-20 | 4 | xslF345X05/form4-05202025_050504.xml | 0001415889-25-013817 | 4911 | ||||||
| 2025-05-20 | 4 | xslF345X05/form4-05202025_050501.xml | 0001415889-25-013816 | 4950 | ||||||
| 2025-05-16 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-003281 | 001-41855 | 25958749 | 33 | 5179 | |||
| 2025-05-16 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-003276 | 001-41855 | 25958719 | 33 | 5128 | |||
| 2025-05-16 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-003275 | 001-41855 | 25958703 | 33 | 5185 | |||
| 2025-05-16 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-003274 | 001-41855 | 25958696 | 33 | 5067 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-002358 | 005-94231 | 25949493 | 34 | 10837 | |||
| 2025-05-15 | 10-Q/A | 10-Q/A | 0000950170-25-071709 | 001-41855 | 25947592 | 34 | 2226371 | 1 | 1 | |
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000131 | 005-94231 | 25943813 | 34 | 10616 | |||
| 2025-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-069774 | 005-94231 | 25937068 | 34 | 141214 | |||
| 2025-05-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-002233 | 005-94231 | 25932839 | 34 | 12460 | |||
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-068536 | 001-41855 | 25932543 | 34 | 9545303 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-068534 | 001-41855 | 25932539 | 34 | 631222 | 1 | 1 |
| 2025-04-28 | ARS | ARS | 0000950170-25-059377 | 001-41855 | 25881232 | 34 | 1420333 | |||
| 2025-04-28 | DEFA14A | DEFA14A | 0000950170-25-059376 | 001-41855 | 25881220 | 34 | 1157364 | |||
| 2025-04-28 | DEF 14A | DEF 14A | 0000950170-25-059375 | 001-41855 | 25881207 | 34 | 2112248 | |||
| 2025-04-28 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-040177 | 005-94231 | 25880171 | 34 | 18001 | |||
| 2025-04-09 | 4 | xslF345X05/form4-04092025_090458.xml | 0001415889-25-010505 | 5065 | ||||||
| 2025-04-09 | 4 | xslF345X05/form4-04092025_090405.xml | 0001415889-25-010503 | 5059 | ||||||
| 2025-04-09 | 4 | xslF345X05/form4-04092025_090448.xml | 0001415889-25-010501 | 5116 | ||||||
| 2025-04-07 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-25-051345 | 001-41855 | 25816270 | 34 | 11889439 | 1 | 1 |
| 2025-04-01 | 4 | xslF345X05/form4-04012025_110414.xml | 0001415889-25-009450 | 4958 | ||||||
| 2025-03-24 | S-8 POS | S-8 POS | 0000950170-25-043855 | 333-286040 | 25764373 | 33 | 675187 | |||
| 2025-03-24 | 424B5 | 424B5 | 0001193125-25-060883 | 333-283781 | 25762233 | 33 | 394545 | |||
| 2025-03-24 | S-8 | S-8 | 0000950170-25-043488 | 333-286040 | 25762200 | 33 | 697494 | |||
| 2025-03-24 | 10-K | 10-K | 0000950170-25-043486 | 001-41855 | 25762197 | 34 | 17831204 | 1 | 1 | |
| 2025-03-24 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-043485 | 001-41855 | 25762195 | 34 | 695146 | 1 | 1 |
| 2025-02-21 | 4 | xslF345X05/form4-02212025_100221.xml | 0001415889-25-005113 | 4920 | ||||||
| 2025-02-21 | 4 | xslF345X05/form4-02212025_100238.xml | 0001415889-25-005110 | 4958 | ||||||
| 2025-02-21 | 4 | xslF345X05/form4-02212025_100209.xml | 0001415889-25-005109 | 4893 | ||||||
| 2025-02-21 | 4 | xslF345X05/form4-02212025_100240.xml | 0001415889-25-005108 | 4901 | ||||||
| 2025-02-19 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-001142 | 001-41855 | 25640511 | 33 | 4583 | |||
| 2025-02-19 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-001141 | 001-41855 | 25640329 | 33 | 4498 | |||
| 2025-02-19 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-001138 | 001-41855 | 25640220 | 33 | 4629 | |||
| 2025-02-19 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-001134 | 001-41855 | 25639952 | 33 | 4485 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001580642-25-001011 | 005-94231 | 25625398 | 34 | 13867 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000055 | 005-94231 | 25625308 | 34 | 10696 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-020474 | 005-94231 | 25623651 | 34 | 20842 | |||
| 2025-02-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-019457 | 005-94231 | 25617901 | 34 | 248102 | |||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000869 | 005-94231 | 25612644 | 34 | 12432 | |||
| 2025-02-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-000640 | 005-94231 | 25587809 | 34 | 11785 | |||
| 2025-01-22 | 4 | xslF345X05/form4-01222025_040101.xml | 0001415889-25-001859 | 7650 | ||||||
| 2025-01-13 | 8-K | 8-K | 8.01 | 0000950170-25-004566 | 001-41855 | 25524819 | 34 | 12811959 | 1 | 1 |
| 2025-01-10 | 4 | xslF345X05/form4-01102025_040110.xml | 0001415889-25-001287 | 7660 | ||||||
| 2025-01-10 | 4 | xslF345X05/form4-01102025_040108.xml | 0001415889-25-001286 | 7655 | ||||||
| 2025-01-10 | 4 | xslF345X05/form4-01102025_040106.xml | 0001415889-25-001285 | 7661 | ||||||
| 2025-01-10 | 4 | xslF345X05/form4-01102025_040103.xml | 0001415889-25-001284 | 7706 | ||||||
| 2025-01-10 | 4 | xslF345X05/form4-01102025_040101.xml | 0001415889-25-001283 | 7641 | ||||||
| 2024-12-27 | 3 | xslF345X02/form3-12272024_071252.xml | 0001415889-24-030197 | 8149 | ||||||
| 2024-12-19 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-12-19 09:00:00 | 9999999995-24-003844 | 333-283781 | 241564898 | 33 | 1753 | ||
| 2024-12-19 | 8-K | 8-K | 5.02,9.01 | 0000950170-24-138224 | 001-41855 | 241560962 | 34 | 543585 | 1 | 1 |
| 2024-12-17 | CORRESP | filename1.htm | 0001193125-24-280121 | 7110 | ||||||
| 2024-12-16 | UPLOAD | filename1.pdf | 0000000000-24-013820 | 333-283781 | 40024 | |||||
| 2024-12-13 | S-3 | S-3 | 0001193125-24-277929 | 333-283781 | 241546872 | 33 | 732676 | |||
| 2024-12-12 | 4 | xslF345X05/form4-12122024_051206.xml | 0001415889-24-029143 | 9542 | ||||||
| 2024-12-10 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-001158 | 001-41855 | 241539425 | 33 | 5986 | |||
| 2024-12-03 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-24-269008,2024-12-03 | 9999999995-24-003642 | 333-278566 | 241524628 | 33 | 1766 | ||
| 2024-12-02 | POS AM | POS AM | 0001193125-24-269008 | 333-278566 | 241519985 | 33 | 297010 | |||
| 2024-11-26 | 4 | xslF345X05/form4-11262024_051101.xml | 0001415889-24-027746 | 4944 | ||||||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119329 | 005-94231 | 241464780 | 34 | 62111 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001193125-24-258717 | 005-94231 | 241463658 | 34 | 72961 | |||
| 2024-11-14 | SC 13G/A | JANUS AMENDMENT | 0001274173-24-000116 | 005-94231 | 241459437 | 34 | 13044 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001580642-24-006954 | 005-94231 | 241459329 | 34 | 55915 | |||
| 2024-11-13 | 4 | xslF345X05/form4-11132024_101138.xml | 0001415889-24-026739 | 5529 | ||||||
| 2024-11-13 | 4 | xslF345X05/form4-11132024_101126.xml | 0001415889-24-026737 | 9542 | ||||||
| 2024-11-13 | 3 | xslF345X02/form3-11132024_101152.xml | 0001415889-24-026735 | 7895 | ||||||
| 2024-11-13 | 424B3 | 424B3 | 0000950170-24-125944 | 333-278566 | 241451196 | 33 | 2033599 | |||
| 2024-11-13 | 10-Q | 10-Q | 0000950170-24-125943 | 001-41855 | 241451194 | 34 | 8685105 | 1 | 1 | |
| 2024-11-13 | 424B3 | 424B3 | 0000950170-24-125941 | 333-278566 | 241451192 | 33 | 450930 | |||
| 2024-11-13 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-24-125940 | 001-41855 | 241451187 | 34 | 668684 | 1 | 1 |
| 2024-11-12 | SC 13G | LEXEO THERAPEUTICS, INC. | 0000902664-24-006396 | 005-94231 | 241444184 | 34 | 66652 | |||
| 2024-10-30 | 424B3 | 424B3 | 0000950170-24-118570 | 333-278566 | 241407266 | 33 | 10848562 | |||
| 2024-10-30 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-118569 | 001-41855 | 241407263 | 34 | 10972730 | 1 | 1 |
| 2024-10-15 | 4 | xslF345X05/form4-10152024_011001.xml | 0001415889-24-025110 | 9544 | ||||||
| 2024-10-09 | 424B3 | 424B3 | 0000950170-24-113765 | 333-278566 | 241363100 | 33 | 22962857 | |||
| 2024-10-09 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-113764 | 001-41855 | 241363091 | 34 | 23086320 | 1 | 1 |
| 2024-09-11 | 4 | xslF345X05/form4-09112024_090900.xml | 0001415889-24-023233 | 9546 | ||||||
| 2024-09-10 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-000808 | 001-41855 | 241290529 | 33 | 6657 | |||
| 2024-08-13 | 4 | xslF345X05/form4-08132024_100801.xml | 0001415889-24-021245 | 9545 | ||||||
| 2024-08-12 | 424B3 | 424B3 | 0000950170-24-095061 | 333-278566 | 241194722 | 33 | 3025938 | |||
| 2024-08-12 | 10-Q | 10-Q | 0000950170-24-095057 | 001-41855 | 241194702 | 34 | 9371615 | 1 | 1 | |
| 2024-08-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-095054 | 001-41855 | 241194694 | 34 | 627829 | 1 | 1 |
| 2024-08-09 | SC 13G/A | SC 13G | 0001580642-24-004416 | 005-94231 | 241190672 | 34 | 81900 | |||
| 2024-08-05 | SC 13G/A | JANUS HENDERSON OWNS LEXEO | 0001274173-24-000075 | 005-94231 | 241173953 | 34 | 12950 | |||
| 2024-07-15 | 424B3 | 424B3 | 0000950170-24-083388 | 333-278566 | 241115886 | 33 | 16545234 | |||
| 2024-07-15 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-083386 | 001-41855 | 241115879 | 34 | 16697179 | 1 | 1 |
| 2024-07-12 | 4 | xslF345X05/form4-07122024_040703.xml | 0001415889-24-019526 | 15038 | ||||||
| 2024-07-08 | 4 | xslF345X05/form4-07082024_100700.xml | 0001415889-24-019380 | 5547 | ||||||
| 2024-07-08 | 3 | xslF345X02/form3-07082024_100703.xml | 0001415889-24-019377 | 7922 | ||||||
| 2024-07-08 | 424B3 | 424B3 | 0000950170-24-081945 | 333-278566 | 241103341 | 33 | 315951 | |||
| 2024-07-08 | 8-K | 8-K | 5.02,8.01,9.01 | 0000950170-24-081942 | 001-41855 | 241103337 | 34 | 520588 | 1 | 1 |
| 2024-06-28 | 424B3 | 424B3 | 0000950170-24-078776 | 333-278566 | 241081392 | 33 | 58097 | |||
| 2024-06-28 | 8-K | 8-K | 5.07 | 0000950170-24-078774 | 001-41855 | 241081373 | 34 | 161495 | 1 | 1 |
| 2024-06-27 | 4 | xslF345X05/form4-06272024_090642.xml | 0001415889-24-018349 | 10324 | ||||||
| 2024-06-27 | 4 | xslF345X05/form4-06272024_090634.xml | 0001415889-24-018348 | 10300 | ||||||
| 2024-06-27 | 4 | xslF345X05/form4-06272024_090647.xml | 0001415889-24-018347 | 10282 | ||||||
| 2024-06-27 | 4 | xslF345X05/form4-06272024_090651.xml | 0001415889-24-018346 | 10349 | ||||||
| 2024-06-27 | 4 | xslF345X05/form4-06272024_090603.xml | 0001415889-24-018343 | 10324 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073371 | 7343 | ||||||
| 2024-06-12 | 4 | xslF345X05/form4-06122024_050602.xml | 0001415889-24-016518 | 11532 | ||||||
| 2024-05-22 | 3 | 3 | 0000950170-24-063572 | 13537 | ||||||
| 2024-05-14 | 4 | 4 | 0000950170-24-059506 | 18421 | ||||||
| 2024-05-13 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-000368 | 001-41855 | 24940306 | 33 | 5210 | |||
| 2024-05-09 | 424B3 | 424B3 | 0000950170-24-056262 | 333-278566 | 24928522 | 33 | 1650101 | |||
| 2024-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-056260 | 001-41855 | 24928516 | 34 | 596789 | 1 | 1 |
| 2024-05-09 | 10-Q | 10-Q | 0000950170-24-056247 | 001-41855 | 24928482 | 34 | 7342657 | 1 | 1 | |
| 2024-04-26 | ARS | ARS | 0000950170-24-048664 | 001-41855 | 24878846 | 34 | 2087869 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0000950170-24-048663 | 001-41855 | 24878838 | 34 | 1124144 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0000950170-24-048662 | 001-41855 | 24878833 | 34 | 1951799 | |||
| 2024-04-22 | 424B3 | 424B3 | 0000950170-24-046200 | 333-278566 | 24859570 | 33 | 434722 | |||
| 2024-04-22 | 424B3 | 424B3 | 0000950170-24-046199 | 333-278566 | 24859564 | 33 | 51241 | |||
| 2024-04-22 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-24-046197 | 001-41855 | 24859562 | 34 | 553064 | 1 | 1 |
| 2024-04-22 | 8-K | FORM 8-K | 5.02 | 0000950123-24-003417 | 001-41855 | 24859555 | 34 | 153929 | 1 | 1 |
| 2024-04-16 | 424B3 | 424B3 | 0000950170-24-044601 | 333-278566 | 24846113 | 33 | 412524 | |||
| 2024-04-16 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-044598 | 001-41855 | 24846108 | 34 | 463089 | 1 | 1 |
| 2024-04-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-04-12 16:30:00 | 9999999995-24-000964 | 333-278566 | 24843019 | 33 | 1752 | ||
| 2024-04-12 | 424B3 | 424B3 | 0001193125-24-094850 | 333-278566 | 24842251 | 33 | 5967705 | |||
| 2024-04-11 | CORRESP | filename1.htm | 0001193125-24-092551 | 6734 | ||||||
| 2024-04-11 | UPLOAD | filename1.pdf | 0000000000-24-003913 | 333-278566 | 40309 | |||||
| 2024-04-09 | S-1 | S-1 | 0001193125-24-090233 | 333-278566 | 24831181 | 33 | 16538956 | 1 | 1 | |
| 2024-03-11 | 8-K | 8-K | 1.01,2.02,3.02,7.01,9.01 | 0000950170-24-029249 | 001-41855 | 24738112 | 34 | 1089501 | 1 | 1 |
| 2024-03-11 | S-8 | S-8 | 0000950170-24-029222 | 333-277816 | 24738051 | 33 | 409680 | |||
| 2024-03-11 | 10-K | 10-K | 0000950170-24-028941 | 001-41855 | 24736761 | 34 | 13904448 | 1 | 1 | |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023927 | 005-94231 | 24639964 | 34 | 137883 | |||
| 2024-02-14 | SC 13G | SC 13G | 0001193125-24-036405 | 005-94231 | 24639562 | 34 | 137658 | |||
| 2024-02-14 | SC 13G | SC 13G | 0001104659-24-023824 | 005-94231 | 24639285 | 34 | 66158 | |||
| 2024-02-14 | SC 13G | JHG PLZ OWNS >5% | 0001274173-24-000061 | 005-94231 | 24635666 | 34 | 10486 | |||
| 2024-02-14 | SC 13G | LEXEO THERAPEUTICS, INC. | 0000902664-24-001520 | 005-94231 | 24631844 | 34 | 65983 | |||
| 2024-02-13 | SC 13G | SC 13G | 0001193125-24-033858 | 005-94231 | 24626874 | 34 | 89814 | |||
| 2024-02-06 | 3 | FORM 3 SUBMISSION | 0001209191-24-002931 | 10633 | ||||||
| 2024-02-06 | 4 | FORM 4 SUBMISSION | 0001209191-24-002930 | 5526 | ||||||
| 2024-02-06 | 4 | FORM 4 SUBMISSION | 0001209191-24-002929 | 5555 | ||||||
| 2024-02-06 | 4 | FORM 4 SUBMISSION | 0001209191-24-002928 | 7698 | ||||||
| 2024-02-05 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-011005 | 001-41855 | 24593931 | 34 | 525402 | 1 | 1 |
| 2024-01-09 | 4 | 4 | 0000950170-24-003466 | 7449 | ||||||
| 2024-01-09 | 4 | 4 | 0000950170-24-003464 | 7337 | ||||||
| 2023-12-18 | 8-K | 8-K | 7.01,9.01 | 0000950170-23-070935 | 001-41855 | 231492222 | 34 | 467462 | 1 | 1 |
| 2023-12-15 | SC 13G/A | SC 13G/A | 0001193125-23-296742 | 005-94231 | 231491072 | 34 | 45103 | |||
| 2023-12-11 | SC 13G | SC 13G | 0001580642-23-006642 | 005-94231 | 231478928 | 34 | 56048 | |||
| 2023-12-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-069193 | 001-41855 | 231476898 | 34 | 701832 | 1 | 1 |
| 2023-12-11 | 10-Q | 10-Q | 0000950170-23-069192 | 001-41855 | 231476897 | 34 | 8940942 | 1 | 1 | |
| 2023-11-24 | SC 13G | SC 13G | 0001193125-23-282769 | 005-94231 | 231436998 | 34 | 40241 | |||
| 2023-11-17 | SC 13G | SC 13G | 0001104659-23-119530 | 005-94231 | 231419084 | 34 | 143254 | |||
| 2023-11-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-054913 | 20244 | ||||||
| 2023-11-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-054910 | 7331 | ||||||
| 2023-11-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-054907 | 12957 | ||||||
| 2023-11-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-054904 | 19411 | ||||||
| 2023-11-07 | S-8 | S-8 | 0001193125-23-272561 | 333-275374 | 231385061 | 33 | 94356 | |||
| 2023-11-07 | 8-K | 8-K | 5.03,9.01 | 0001193125-23-272430 | 001-41855 | 231383819 | 34 | 157823 | ||
| 2023-11-06 | SEC STAFF LETTER | filename1.pdf | 9999999997-23-004630 | 64028 | ||||||
| 2023-11-06 | 424B4 | 424B4 | 0001193125-23-271432 | 333-274777 | 231380571 | 33 | 9094672 | |||
| 2023-11-03 | FWP | FWP | 0001193125-23-269627 | 333-274777 | 231374220 | 34 | 9630 | |||
| 2023-11-02 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-11-02 16:00:00 | 9999999995-23-003175 | 333-274777 | 231374363 | 33 | 1731 | ||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054282 | 11100 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054280 | 10443 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054278 | 17641 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054276 | 12670 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054275 | 6082 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054273 | 19020 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054267 | 6573 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054264 | 6601 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054260 | 7841 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054259 | 8710 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054258 | 9077 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054257 | 6616 | ||||||
| 2023-11-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-054256 | 11482 | ||||||
| 2023-11-02 | CERT | 8A_cert_LXEO.pdf | 0001354457-23-000803 | 001-41855 | 231373431 | 34 | 179773 | |||
| 2023-11-01 | CORRESP | filename1.htm | 0001193125-23-268318 | 16699 | ||||||
| 2023-11-01 | S-1/A | S-1/A | 0001193125-23-268301 | 333-274777 | 231369042 | 33 | 9230143 | |||
| 2023-11-01 | 8-A12B | 8-A12B | 0001193125-23-268168 | 001-41855 | 231368104 | 34 | 14261 | |||
| 2023-11-01 | UPLOAD | filename1.pdf | 0000000000-23-011955 | 44514 | ||||||
| 2023-10-31 | CORRESP | filename1.htm | 0001193125-23-267298 | 10475 | ||||||
| 2023-10-31 | CORRESP | filename1.htm | 0001193125-23-267290 | 9030 | ||||||
| 2023-10-30 | S-1/A | S-1/A | 0001193125-23-265646 | 333-274777 | 231357145 | 33 | 10444529 | |||
| 2023-10-05 | CORRESP | filename1.htm | 0001193125-23-251767 | 78054 | ||||||
| 2023-09-29 | S-1 | S-1 | 0001193125-23-247367 | 333-274777 | 231295400 | 33 | 11773964 | |||
| 2023-09-19 | SEC STAFF LETTER | filename1.pdf | 9999999997-23-004208 | 65374 | ||||||
| 2023-09-18 | DRSLTR | filename1.htm | 0000950123-23-008567 | 24014 | ||||||
| 2023-09-18 | DRS/A | filename1.htm | 0000950123-23-008566 | 377-05985 | 231261464 | 33 | 10485282 | |||
| 2023-08-18 | UPLOAD | filename1.pdf | 0000000000-23-009040 | 46852 | ||||||
| 2023-08-16 | DRS/A | filename1.htm | 0000950123-23-008288 | 377-05985 | 231176284 | 33 | 9143767 | |||
| 2023-08-15 | DRSLTR | filename1.htm | 0000950123-23-008284 | 27790 | ||||||
| 2023-06-13 | UPLOAD | filename1.pdf | 0000000000-23-006355 | 50468 | ||||||
| 2023-05-17 | DRSLTR | filename1.htm | 0000950123-23-005541 | 22584 | ||||||
| 2023-05-17 | DRS/A | filename1.htm | 0000950123-23-005540 | 377-05985 | 23932008 | 33 | 8320110 | |||
| 2022-05-17 | UPLOAD | filename1.pdf | 0000000000-22-005394 | 46999 | ||||||
| 2022-05-05 | DRSLTR | filename1.htm | 0000950123-22-004600 | 61267 | ||||||
| 2022-05-05 | DRS/A | filename1.htm | 0000950123-22-004599 | 377-05985 | 22894484 | 33 | 6703686 | |||
| 2022-03-03 | UPLOAD | filename1.pdf | 0000000000-22-002410 | 65856 | ||||||
| 2022-02-04 | DRS | filename1.htm | 0000950123-22-001044 | 377-05985 | 22594435 | 33 | 5432124 |
One latest value per concept from companyfacts (202 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 82.79M | 2026-11-12 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 216.50M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 15,952.56 | 2026-10-28 | S-3 | 2026-10-29 | 0001193125-26-437001 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 15,952.56 | 2026-10-28 | S-3 | 2026-10-29 | 0001193125-26-437001 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 300.00M | 2026-10-28 | S-3 | 2026-10-29 | 0001193125-26-437001 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-28 | S-3 | 2026-10-29 | 0001193125-26-437001 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-10-28 | S-3 | 2026-10-29 | 0001193125-26-437001 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 3.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | -19,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 1.03M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0000950170-25-068536 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.08M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-028941 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 974,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -465,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 681.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | USD | 4.42M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 12.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | Assets | Assets | USD | 243.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 204.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 188,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 465,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 129.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-265757 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 81.77M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-265757 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 128.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 104.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 24.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 141,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-028941 |
| us-gaap | CapitalizedComputerSoftwareGross | Capitalized Computer Software, Gross | USD | 100,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | CapitalUnitsAuthorized | Capital Units, Authorized | shares | 510.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 90.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 219.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 93.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 27.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 33.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 82.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 82.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 8,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -85.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 185.03M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 4.15M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-12-11 | 0000950170-23-069192 | |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 4.42M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 24,000 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0000950170-25-108427 |
| us-gaap | DeferredCostsCurrentAndNoncurrent | Deferred Costs | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 2.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 121.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 43.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 2.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 56.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 6.22M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 7.19M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 118.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 2.06M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 380,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 233,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | DividendsCommonStockCash | Dividends, Common Stock, Cash | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.99 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.99 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.165 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.005 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.01 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.107 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.037 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.055 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 20.80M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0000950170-24-125943 | |
| us-gaap | EquitySecuritiesFVNINoncurrent | EquitySecuritiesFVNINoncurrent | USD | 3.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 43,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 449,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 420,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 29,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 468,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueAfterYearFive | Finance Lease, Liability, to be Paid, after Year Five | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 313,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFive | Finance Lease, Liability, to be Paid, Year Five | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 8,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 147,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 19,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 398,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 900,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 240,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.087 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | GainLossOnFairValueHedgesRecognizedInEarnings | Gain (Loss) on Fair Value Hedges Recognized in Earnings | USD | -530,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 21.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -99.67M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -84.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 551,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 551,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 16.43M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -20.93M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 948,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncomeTaxReconciliationTaxCreditsForeign | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount | USD | 10.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -5.52M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -1.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 6.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -46,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-028941 |
| us-gaap | IncreaseDecreaseInDerivativeAssetsAndLiabilities | Increase (Decrease) in Derivative Assets and Liabilities | USD | -530,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 4.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | IncreaseDecreaseInPropertyAndOtherTaxesPayable | Increase (Decrease) in Property and Other Taxes Payable | USD | -349,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-028941 |
| us-gaap | IncreaseDecreaseInSecurityDeposits | Increase (Decrease) in Security Deposits | USD | 2,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-028941 |
| us-gaap | InterestExpense | Interest Expense | USD | 72,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-12 | 0000950170-24-095057 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 43,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 104,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | InvestmentIncomeAmortizationOfDiscount | Investment Income, Amortization of Discount | USD | 23,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | InvestmentIncomeAmortizationOfPremium | Investment Income, Amortization of Premium | USD | 106,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-265757 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 6.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | -19,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 6.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 2.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.37M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 559,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 712,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | Liabilities | Liabilities | USD | 27.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 243.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 23.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 7.04M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0000950170-25-068536 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 40.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 53.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -67.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -84.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 6.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 90.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -90.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 2.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 5.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 2.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 3.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 5.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 165,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 3,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-028941 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -653,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -16,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 86,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 1.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 31.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 340,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | PaymentsToAcquireSoftware | Payments to Acquire Software | USD | 13,000 | 2024-01-01 | 2024-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-265757 |
| us-gaap | PreferredStockConvertibleSharesIssuable | PreferredStockConvertibleSharesIssuable | shares | 13.56M | 2023-11-07 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 10.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 2.83M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-028941 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 4.00M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 80.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 39.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 185.56M | 2021-08-10 | 2023-11-07 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 20,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-028941 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 95.00M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 85.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 329,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 2.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -84.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 2.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 1.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 69.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 3.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -464.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 654,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-028941 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 12.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.85 | 2023-11-07 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 5.46 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 33.06M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0000950170-24-125943 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 70.92M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0000950170-25-068536 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 216.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 185.03M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 2.45M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 3.69M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 320,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 17,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 36,000 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-12 | 0000950170-24-095057 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 185.56M | 2023-11-07 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 143.65M | 2023-11-07 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 143.65M | 2023-11-07 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 143.65M | 2023-11-07 | 2024 | FY | 10-K | 2025-03-24 | 0000950170-25-043486 | |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 3,827 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | TreasuryStockCommonValue | Treasury Stock, Common, Value | USD | 17,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -653,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 23.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132085 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 387,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 85.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 85.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |
| us-gaap | WorkersCompensationLiabilityCurrent | Workers' Compensation Liability, Current | USD | 3.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462020 |